Article

Lifestyle-related factors in predementia and dementia syndromes.

Department of Geriatrics, Center for Aging Brain, Memory Unit, University of Bari, Bari, Italy.
Expert Review of Neurotherapeutics (Impact Factor: 2.83). 02/2008; 8(1):133-58. DOI: 10.1586/14737175.8.1.133
Source: PubMed

ABSTRACT Cognitive decline and dementia have a deep impact on the health and quality of life of older subjects and their caregivers. Since the therapeutic options currently available have demonstrated limited efficacy, the search for preventive strategies for cognitive decline and dementia are mandatory. A possible role of lifestyle-related factors was recently proposed for age-related changes of cognitive function, predementia syndromes and the cognitive decline of degenerative (Alzheimer's disease [AD]) or vascular origin. At present, cumulative evidence suggests that vascular risk factors may be important in the development of mild cognitive impairment (MCI), dementia and AD. Moderate alcohol drinking has been proposed as a protective factor against MCI and dementia in several longitudinal studies, but contrasting findings also exist. The Mediterranean diet could therefore be an interesting model with which to further study the association between dietary patterns and cognitive functioning, given the suggested role of many components of this diet (monounsaturated fatty acids, polyunsaturated fatty acids, cereals and red wine) in contrasting cognitive impairment and dementia. The association between low education and predementia and dementia syndromes is supported by the majority of studies, but very few studies have investigated whether this association may be attributed with lifestyle factors that covary with education. Studies in the literature seem to identify in physical exercise one promising strategy in decreasing cognitive decline, but some of the limitations of these studies do not allow us to draw definite conclusions. At present, in older subjects, healthy diets, antioxidant supplements, the prevention of nutritional deficiencies, and moderate physical activity could be considered the first line of defense against the development and progression of predementia and dementia syndromes. However, in most cases, these were only observational studies, and results are awaited from large multicenter randomized clinical trials in older persons that may clarify the possible synergy, for example, between moderate exercise, physical activity and healthy Mediterranean diet on cognition in the elderly.

1 Follower
 · 
251 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Export Date: 18 October 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A doença de Parkinson (DP) é a doença neurodegenerativa motora mais prevalente na população, com maior incidência nos idosos. Algumas características importantes desta doença, como o seu caráter progressivo, a presença de sintomas não motores que em grande parte não respondem aos fármacos antiparkinsonianos disponíveis atualmente, e a perda de eficácia e o aparecimento de efeitos colaterais sérios após o tratamento crônico com fármacos dopaminérgicos, representam verdadeiros desafios às comunidades clínica e acadêmica. Existe um grande esforço na busca de agentes neuroprotetores e modificadores da DP, ou que aliviem os efeitos colaterais do tratamento, principalmente as discinesias, associados ao uso crônico da L-DOPA. Nas últimas duas décadas, um número crescente de trabalhos clínicos e experimentais tem sugerido o potencial do exercício físico como um agente paliativo ou adjuvante na DP. Os resultados desta tese demonstram que a capacidade neuroprotetora do exercício físico é dependente do modelo experimental utilizado, sendo observada em camundongos hemiparkinsonianos após lesão unilateral com 6-OHDA intra-estriatal. A prevenção da disfunção mitocondrial e do estresse oxidativo são mecanismos potencialmente envolvidos nesta ação neuroprotetora do exercício. Por outro lado, o mesmo protocolo de corrida em esteira durante seis semanas não protegeu a degeneração da via nigro-estriatal induzida pelo tratamento intranasal com MPTP em camundongos. Além disso, foi possível caracterizar uma série de propriedades modificadoras do exercício nos modelos experimentais da DP utilizados no presente estudo. O exercício em esteira ergométrica durante seis semanas atenuou os prejuízos motores e cognitivos induzidos, respectivamente, pela administração intra-estriatal de 6-OHDA e intranasal de MPTP em camundongos. Enquanto o exercício voluntário durante 14 dias em rodas de correr reduziu a severidade das discinesias induzidas pela L-DOPA em camundongos hemiparkinsonianos. Estes benefícios foram acompanhados de importantes modificações na plasticidade dos núcleos da base dos animais exercitados. O exercício melhorou a função da via indireta dos núcleos da base nos animais tratados com MPTP, através do aumento do número e resposta de receptores do tipo D2 para dopamina e da diminuição do turnover dopaminérgico. O exercício também preveniu modificações na neurotransmissão glutamatérgica e sinalização intracelular no estriado, potencialmente envolvidas no desenvolvimento das discinesias induzidas pela L-DOPA. Em conjunto, os resultados do presente estudo indicam o potencial do exercício físico como um agente modificador da DP, sendo este capaz de aliviar os prejuízos motores e cognitivos em animais submetidos a modelos experimentais da DP, além de diminuir as discinesias induzidas pelo tratamento com L-DOPA, enquanto a neuroproteção ainda permanece controversa. Palavras-chave: Exercício; doença de Parkinson; 6-OHDA; MPTP; L-DOPA, comportamento; neuroproteção; discinesias.
    08/2011, Degree: PhD, Supervisor: Rui Prediger
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A prolonged preclinical phase of more than two decades before the onset of dementia suggested that initial brain changes of Alzheimer’s disease (AD) and the symptoms of advanced AD may represent a unique continuum. Given the very limited therapeutic value of drugs currently used in the treatment of AD and dementia, preventing or postponing the onset of AD and delaying or slowing its progression are becoming mandatory. Among possible reversible risk factors of dementia and AD, vascular, metabolic, and lifestyle-related factors were associated with the development of dementia and late-life cognitive disorders, opening new avenues for the prevention of these diseases. Among diet-associated factors, coffee is regularly consumed by millions of people around the world and owing to its caffeine content, it is the best known psychoactive stimulant resulting in heightened alertness and arousal and improvement of cognitive performance. Besides its short-term effect, some case-control and cross-sectional and longitudinal population-based studies evaluated the long-term effects on brain function and provided some evidence that coffee, tea, and caffeine consumption or higher plasma caffeine levels may be protective against cognitive impairment/decline and dementia. In particular, several cross-sectional and longitudinal population-based studies suggested a protective effect of coffee, tea, and caffeine use against late-life cognitive impairment/decline, although the association was not found in all cognitive domains investigated and there was a lack of a distinct dose-response association, with a stronger effect among women than men. The findings on the association of coffee, tea, and caffeine consumption or plasma caffeine levels with incident mild cognitive impairment and its progression to dementia were too limited to draw any conclusion. Furthermore, for dementia and AD prevention, some studies with baseline examination in midlife pointed to a lack of association, although other case-control and longitudinal population-based studies with briefer follow-up periods supported favourable effects of coffee, tea, and caffeine consumption against AD. Larger studies with longer follow-up periods should be encouraged, addressing other potential bias and confounding sources, so hopefully opening new ways for diet-related prevention of dementia and AD.
    The Journal of Nutrition Health and Aging 12/2014; 19(3). DOI:10.1007/s12603-014-0563-8 · 2.66 Impact Factor